ÂÜÀòÂÒÂ×

Focusing on patent portfolios for clients in the chemical and life sciences sectors, Mark not only executes the patent procurement process with an emphasis on quality and timeliness, he excels at setting filing strategies that effectively cover his clients’ immediate, mid-term, and long-term protection needs.

Mark is more than a professional who provides a service – he is genuinely interested in adding value to his clients and is invested in the success of their businesses. With a broad knowledge of IP laws beyond Canada and the United States, Mark offers clients a unique understanding of other jurisdictions that may serve to strengthen their positions in a global market.

Mark’s practice encompasses the development and management of patents for biologics, drug discovery, diagnostics and medical devices, and natural products. He also represents clients in respect of their licenses, acquisitions, research and development agreements and other intellectual property transactions.

He regularly prepares international patent applications and advises clients throughout subsequent patent prosecution in various jurisdictions, including Canada, Europe, the United States and Australia. He also prosecutes Canadian patent applications for clients in the United States, Europe and other jurisdictions. Mark has successfully represented clients before the Patent Appeal Board.

After obtaining a Ph.D. in developmental genetics from the University of British Columbia, Mark was a research associate at Brookhaven National Laboratory where he worked on the metabolic engineering of designer oils in oilseed crops. He has also worked on the molecular farming of enzyme therapies for rare metabolic disorders. Mark’s work has been published in several peer-reviewed journals including the Proceedings of the National Academy of Sciences (U.S.A.), and patented as US9340776, US9976155 and EP2585599.

Mark is currently co-chair of the AIPLA’s Plant Biotechnology Subcommittee.